NRSNW
NeuroSense Therapeutics Ltd. Warrant (NRSNW)
$42
About NeuroSense Therapeutics Ltd. Warrant (NRSNW)
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Details
Daily high
$0.42
Daily low
$0.39
Price at open
$0.44
52 Week High
$0.65
52 Week Low
$0.08
Market cap
--
Dividend yield
0.00%
Volume
1,055
Avg. volume
1,514
P/E ratio
--
NeuroSense Therapeutics Ltd. Warrant News
Details
Daily high
$0.42
Daily low
$0.39
Price at open
$0.44
52 Week High
$0.65
52 Week Low
$0.08
Market cap
--
Dividend yield
0.00%
Volume
1,055
Avg. volume
1,514
P/E ratio
--